<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01832454</url>
  </required_header>
  <id_info>
    <org_study_id>00160</org_study_id>
    <nct_id>NCT01832454</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below 15 Years</brief_title>
  <acronym>BMCP2</acronym>
  <official_title>Safety and Efficacy of Bone Marrow MNC for the Treatment of Cerebral Palsy in Subjects Below Years. It is Self Funded (Patients' Own Funding) Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chaitanya Hospital, Pune</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chaitanya Hospital, Pune</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Study is Single arm, Single Centre trail to check the safety and efficacy of bone marrow
      derived autologous mononuclear cells(100 millions per dose )trial to be conducted for 36
      months in 100 patients ( below 15 years of age) with cerebral palsy in India. Primary outcome
      measures are improvement in walking ability and kinetic gait pattern.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This Study is Single arm, Single Centre trail to check the safety and efficacy of bone marrow
      derived autologous mononuclear cells(100 millions per dose )trial to be conducted for 36
      months in 100 patients ( below 15 years of age) with cerebral palsy in India. Primary outcome
      measures are improvement in walking ability and kinetic gait pattern
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2011</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in muscle rigidity using Ash worth scale and overall motor control using oxford scale.</measure>
    <time_frame>6 months</time_frame>
    <description>- Improvement in muscle rigidity using Ash worth scale and overall motor control using oxford scale at Time point - 6 Months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>-Improvement in IQ by using Benit Kamat scale.</measure>
    <time_frame>6 Months</time_frame>
    <description>-Improvement in IQ by using Benit Kamat scale. Improvement in social behaviour. Reduction in deformity.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Intra thecal inj of autologous MNC</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Intra thecal inj of autologous MNC</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intra thecal inj of autologous MNC</intervention_name>
    <description>Intra thecal inj of autologous MNC</description>
    <arm_group_label>Intra thecal inj of autologous MNC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject aged above 3 years and below 15 years with a diagnosis of Cerebral Palsy.

          -  Regional Nerve damage as shown by Magnetic Resonance Imaging(MRI)

          -  Able to Comprehend and give written informed consent form for the study

          -  willing to come to the hospital for follow up visits as per the protocol requirements

        Exclusion Criteria:

          -  History of meningitis,meningoencephalits,epilepsy or life threatening allergic or
             immune -mediated reaction 2

          -  Hemodynamically unstable patients

          -  history of or concurrent autoimmune disease or acute episode if Guillain- barre
             syndrome

          -  peripheral Muscular dystropy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anant E Bagul, M.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>chaitanya stem cell centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chaitnany Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <zip>411009</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sachin A Jamadar, D ORTHO</last_name>
      <phone>+918888788880</phone>
      <email>sac2751982@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dr, Anant E Bagul, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2013</study_first_submitted>
  <study_first_submitted_qc>April 12, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2013</study_first_posted>
  <last_update_submitted>September 16, 2014</last_update_submitted>
  <last_update_submitted_qc>September 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chaitanya Hospital, Pune</investigator_affiliation>
    <investigator_full_name>Dr. Sachin Jamadar</investigator_full_name>
    <investigator_title>CO-Investigator</investigator_title>
  </responsible_party>
  <keyword>cerebral palsy stem cells [MNCS]</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

